SkinHealth Systems Inc. splits its revenue into 2 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Consumables at $212.7 million, 71% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2026
Sep 30, 2026
|
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 31, 2021
|
FY 2020
Dec 31, 2020
|
|---|---|---|---|---|---|---|---|
| Revenue |
289
|
301
|
334
|
398
|
366
|
260
|
—
|
| Consumables |
208
-1.6%
share 72.2%
|
213
+1.8%
share 70.7%
|
209
+9.2%
share 62.5%
|
191
+19.9%
share 48.1%
|
160
+32.3%
share 43.6%
|
121
+83.5%
share 46.4%
|
66
|
| Delivery Systems |
80
-11.0%
share 27.8%
|
88
-29.8%
share 29.3%
|
125
-39.3%
share 37.5%
|
207
+0.2%
share 51.9%
|
206
+47.9%
share 56.4%
|
139
+161.3%
share 53.6%
|
53
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- SKIN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Long Beach, CA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1818093
- Former names
- Beauty Health Co (until Apr 20, 2026); Vesper Healthcare Acquisition Corp. (until Apr 30, 2021)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.